Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience-Reference-Cited by-同舟云学术

Role of Liver Stiffness Measurement in Predicting HCC Occurrence in Direct-Acting Antivirals Setting: A Real-Life Experience

Published:2019-04-01 Issue:10 Volume:64 Page:3013-3019
ISSN:0163-2116
Container-title:Digestive Diseases and Sciences
language:en
Short-container-title:Dig Dis Sci

Author:

Rinaldi Luca^ORCID,Guarino Maria,Perrella Alessandro,Pafundi Pia Clara,Valente Giovanna,Fontanella Luca,Nevola Riccardo,Guerrera Barbara,Iuliano Natalina,Imparato Michele,Trabucco Alessio,Sasso Ferdinando Carlo,Morisco Filomena,Ascione Antonio,Piai Guido,Adinolfi Luigi Elio

Publisher

Springer Science and Business Media LLC

Subject

Gastroenterology,Physiology

Link

http://link.springer.com/content/pdf/10.1007/s10620-019-05604-8.pdf

Reference36 articles.

1. Pawlotsky JM. New hepatitis C therapies: the toolbox, strategies, and challenges. Gastroenterology. 2014;146:1176–1192. https://doi.org/10.1053/j.gastro.2014.03.003 .

2. Morisco F, Loperto I, Stroffolini T, et al. Prevalence and risk factors of HCV infection in a metropolitan area in southern Italy: tail of a cohort infected in past decades. J Med Virol. 2017;89:291–297. https://doi.org/10.1002/jmv.24635 .

3. Morisco F, Granata R, Stroffolini T, et al. Sustained virological response: a milestone in the treatment of chronic hepatitis C. World J Gastroenterol. 2013;19:2793–2798. https://doi.org/10.3748/wjg.v19.i18.2793 .

4. Foucher J, Chanteloup E, Vergniol J, et al. Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study. Gut. 2006;55:403–408. https://doi.org/10.1136/gut.2005.069153 .

5. Rinaldi L, Valente G, Piai G. Serial liver stiffness measurements and monitoring of liver- transplanted patients in a real-life in clinical practice. Hepat Mon. 2016;16:e41162. https://doi.org/10.5812/hepatmon.41162 .

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma by suppressing MEK/ERK and CREB/Bcl-xl pathways;International Immunopharmacology;2024-09

2. Liver and spleen stiffness measurement in the prediction of hepatocellular carcinoma in chronic liver disease;Exploration of Digestive Diseases;2024-08-21

3. Development and validation of a nomogram for assessing hepatocellular carcinoma risk after SVR in hepatitis C patients with advanced fibrosis and cirrhosis;Infectious Agents and Cancer;2024-04-25

4. APG-1252 combined with Cabozantinib inhibits hepatocellular carcinoma through MEK/ERK and CREB/Bcl-xl pathways;2024-04-08

5. Recent advances in various adeno-associated viruses (AAVs) as gene therapy agents in hepatocellular carcinoma;Virology Journal;2024-01-12